SLC2A4RG and Alzheimer disease: These trends, in addition to support for SLC2A4RG as an eGene in CD4+ T cells [58–60], nominate potential molecular mechanisms, specific TFs (MYB and FOXP1) that might alter the expression of genes important to T cell function in AD patients.